Dynamic variations in peripheral blood indices and their association with efficacy and adverse reactions of pd- 1 inhibitor combined chemotherapy in patients with advanced gastric cancer.

[ 53 ] encompassing various tumor types, demonstrated that irAEs in patients treated with anti-PD- 1/PD-L1 inhibitors were significantly associated with improved ORR and PFS.The analyses from our study corroborate these findings, indicating that patients suffering from irAEs exhibited improved PFS outcomes; however, due to the small sample size, this difference did not reach statistical significance.

also in 111,027 other papers